Synapse Medicine
Signal active
Organization
Contact Information
Overview
At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone.
To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey.
Synapse is working with world-leading hospitals and digital health companies in the United States, Europe and Japan to transform today’s medication regimens into tomorrow’s medication success.
About
Industries
Software, Health Care, Pharmaceutical, Medical, Medical Device
Founded
2017
Employees
51-100
Headquarters locations
Europe
Social
N/A
Profile Resume
Synapse Medicine headquartered in Europe, operates in the Software, Health Care, Pharmaceutical, Medical, Medical Device sector. The company focuses on Software and has secured $2.3B in funding across 60 round(s). With a team of 51-100 employees, Synapse Medicine is actively contributing to advancements in Software. Their latest funding round, Series B - Synapse Medicine, raised $27.8M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
5
Lead Investors
0
Total Funding Amount
$38.7M
Details
3
Synapse Medicine has raised a total of $38.7M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Seed | 2.8M | ||
| 2020 | Early Stage Venture | 8.0M | ||
| 2022 | Early Stage Venture | 27.8M |
Investors
Synapse Medicine is funded by 21 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| BNP Paribas Développement | - | FUNDING ROUND - BNP Paribas Développement | 27.8M |
| Fleur Pellerin | - | FUNDING ROUND - Fleur Pellerin | 27.8M |
| Synapse Medicine | - | FUNDING ROUND - Synapse Medicine | 27.8M |
| Korelya Capital | - | FUNDING ROUND - Korelya Capital | 27.8M |
Recent Activity
There is no recent news or activity for this profile.